COMMUNIQUÉS West-GlobeNewswire

-
Immunomedics to Report Results for the Quarter and Six Months Ended December 31, 2018 and Host Conference Call and Webcast on February 25, 2019
19/02/2019 -
CymaBay Therapeutics Announces Early Enrollment of a Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis
19/02/2019 -
Private Placement of $366,666
19/02/2019 -
Placement privé de 366 666 $
19/02/2019 -
Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis
19/02/2019 -
Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019
19/02/2019 -
Amedisys Announces Retirement of Board Member Linda J. Hall
19/02/2019 -
Spark Therapeutics Reports 2018 Financial Results and Recent Business Progress
19/02/2019 -
Iterum to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
19/02/2019 -
Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference
19/02/2019 -
Aptinyx Initiates Phase 2 Study to Evaluate Safety and Efficacy of NYX-783 in Patients with Post-Traumatic Stress Disorder
19/02/2019 -
Clearside Biomedical’s Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society
19/02/2019 -
The Joint Corp. Opens First Corporately Managed Greenfield Clinic Since 2016
19/02/2019 -
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
19/02/2019 -
Axovant to Present at 8th Annual SVB Leerink Global Healthcare Conference
19/02/2019 -
William Demant Holding A/S: Notice to annual general meeting
19/02/2019 -
Transactions in relation to share buyback program
19/02/2019 -
Helsinn Investment Fund Invests €1 Million in Gain Therapeutics
19/02/2019 -
Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany
19/02/2019
Pages